✦ LIBER ✦

Will the use of low-molecular-weight heparin (enoxaparin) in patients with acute coronary syndrome save costs in Canada?

✍ Scribed by Bernie J. O'Brien; Andrew Willan; Gordon Blackhouse; Ron Goeree; Marc Cohen; Shaun Goodman

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Low-Molecular-Weight Heparins in the Man

✍ Javier Borja 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 39 KB

Thrombotic Reactant Markers in Non-ST Se

✍ Enrique Gurfinkel; Ernesto Duronto; Cecilia Colorio; Gerardo Bozovich; Marc Cohe 📂 Article 📅 1999 🏛 Springer US 🌐 English ⚖ 90 KB

Low-Molecular-Weight Heparin Should Repl

✍ Peter J. Zed 📂 Article 📅 1999 🏛 Springer US 🌐 English ⚖ 98 KB

Efficacy and safety of the low-molecular

✍ Murphy, S. A.; Gibson, C. M.; Morrow, D. A.; Van de Werf, F.; Menown, I. B.; Goo 📂 Article 📅 2007 🏛 Oxford University Press 🌐 English ⚖ 656 KB

Use of low molecular weight heparins in

✍ Brian H. Rowe; Eddy S. Lang 📂 Article 📅 2002 🏛 Elsevier Science 🌐 English ⚖ 52 KB

Low-molecular-weight heparin in patients

✍ Shaun G Goodman 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 735 KB